Skip to main content

Day: April 30, 2024

Full-scale Lilium Jet model to be unveiled for the first time at EBACE2024

The first public unveiling of full-scale Lilium Jet model is set to occur next month in Geneva The Lilium Jet model will be located at Stand A39, as part of Lilium’s largest EBACE presence to date and as one of the show’s largest exhibitors The showcase will also feature the Lilium Jet charging infrastructure and an immersive flight simulator experience for visitorsMUNICH, Germany, April 30, 2024 (GLOBE NEWSWIRE) — Lilium N.V. (NASDAQ: LILM), developer of the first all-electric vertical take-off and landing (“eVTOL”) jet and global pioneer in Regional Air Mobility (RAM), today announced that it will unveil the full-scale Lilium Jet model for the first time at EBACE2024: Europe’s premier aviation and advanced air mobility event, taking place 28-30 May 2024 in Geneva, Switzerland at Palexpo and Geneva Airport. This will be the...

Continue reading

Inside information, profit warning: KH Group Plc lowers its guidance for 2024

KH Group Plc Inside information, 30 April 2024 at 2.30 pm EEST Inside information, profit warning: KH Group Plc lowers its guidance for 2024 KH Group Plc lowers its guidance for 2024. In the 2023 Financial Statements Release published on 21 March 2024, the company estimated net sales of EUR 400–420 million and operating profit of EUR 14–16 million for the financial year 2024. The guidance did not include the operating profit of approximately EUR 3.7 million from Indoor Group’s real estate sale in Estonia, which the company announced on 21 March 2024 at 12 noon. According to the updated guidance, the company estimates, with the current Group structure, to reach net sales of EUR 400–420 million and operating profit of EUR 12–16 million in 2024, including the operating profit from the real estate sale in Estonia. The lowering of the guidance...

Continue reading

MiNK to Provide Corporate Update and First Quarter 2024 Financial Report

NEW YORK, April 30, 2024 (GLOBE NEWSWIRE) — MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases, today announced that the Company will release its first quarter 2024 financial results before the market opens on Tuesday, May 14, 2024. MiNK executives will host a conference call and webcast at 8:30 a.m. ET that morning to discuss the results and to provide a corporate update. Conference Call Dial-in numbers: 646-307-1963 (U.S. – NY), (800) 715-9871 (U.S. & Canada) Conference ID: 7888464 Webcast A live webcast and replay of the conference call will be accessible from the Events & Presentations page of...

Continue reading

Metasphere Labs Announces Record-Breaking Achievement by Jimi Cohen

VANCOUVER, British Columbia, April 30, 2024 (GLOBE NEWSWIRE) — Metasphere Labs Inc. (“Metasphere” or the “Company”) (Cboe Canada: LABZ) (OTC: LABZF) (FRA: H1N) is proud to announce that Jimi Cohen, founder of The Treegens (“Treegens”), a leader in the Web3 Regenerative Finance (ReFi) sector, has set a new world record by planting 30,297 mangrove trees in a single day in the Majoreni of Shimoni, Kenya. This remarkable achievement, currently under evaluation by Guinness World Records, marks the third consecutive year that Mr. Cohen has set the tree planting world record. About Treegens Treegens, spearheaded by its passionate community and the innovative Treegens DAO, is revolutionizing the environmental impact sector through blockchain technology, AI, and gamification. The platform focuses on mangrove trees...

Continue reading

Comedian Jay Du Temple Becomes Brand Ambassador for GURU Organic Energy

GURU Organic EnergyJay Du Temple becomes brand ambassador for GURU Organic EnergyGURU will be the content partner for Jay Du Temple’s “FIN” Canadian tour. The partnership calls for Jay Du Temple’s participation in GURU’s marketing and social media campaigns and mutual creative projects for the Quebec market.MONTREAL, April 30, 2024 (GLOBE NEWSWIRE) — GURU Organic Energy Corp. (TSX: GURU) (“GURU” or the “Company”), Canada’s leading organic energy drink brand1, is thrilled to announce an innovative and humor-filled partnership with Quebec comedian and host Jay Du Temple. GURU will notably be the content partner for Jay Du Temple’s FIN Canadian tour, with Jay becoming a GURU shareholder and brand ambassador. Carl Goyette, President and CEO of GURU, said: “We’re proud to welcome Jay, a rising...

Continue reading

Hubbell Reports First Quarter 2024 Results

Shelton, CT, April 30, 2024 (GLOBE NEWSWIRE) — HUBBELL REPORTS FIRST QUARTER 2024 RESULTSQ1 diluted EPS of $2.73; adjusted diluted EPS of $3.60 Q1 net sales +9% (organic +2%; net M&A +6%) Operating margin -310 bps year-over-year; adjusted operating margin -100 bps Anticipate FY24 diluted EPS of $14.10-$14.60; reaffirm adj. diluted EPS of $16.00-$16.50Hubbell Incorporated (NYSE: HUBB) today reported operating results for the first quarter ended March 31, 2024. “Hubbell is off to a solid start in 2024,” said Gerben Bakker, Chairman, President and CEO. “Operating performance was highlighted by strong organic growth in our Electrical Solutions segment, where electrification drove broad-based strength across industrial markets and continued execution on our segment unification strategy drove operating profit growth and margin...

Continue reading

Macerich Reports First Quarter 2024 Results

SANTA MONICA, Calif., April 30, 2024 (GLOBE NEWSWIRE) — The Macerich Company (NYSE: MAC) has released its First Quarter 2024 Earnings Results and Supplemental Information by posting it to the Investor Relations section of its website at www.macerich.com. As previously announced, management will hold a conference call at 10:00 a.m. Pacific Time (1:00 p.m. Eastern Time) today, Tuesday, April 30, 2024, to discuss quarterly results. Participants who wish to join the conference by telephone must register at the dial-in registration link below to receive the dial-in number and a personalized PIN code that will be required to access the call. Participants may join the live webcast by accessing it at the webcast registration link below or in the Investors Section of the company’s website at https://investing.macerich.com/. Dial-In Registration:...

Continue reading

Entourage Health Reports Fiscal Year 2023 Financial Results and Posts $54 Million in Total Revenues

Strategic Cost Management Signals Stronger Financial Health and Future StabilityGross profit before fair value changes reached $2.4 million, reflecting a 126% year-over-year increase. Company demonstrates financial gains with a 23% reduction in the cost of goods sold. SG&A declined 14% compared to the previous year. Color Cannabis secures a #6 spot in the national pre-roll market.TORONTO, April 30, 2024 (GLOBE NEWSWIRE) — Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE: 4WE) (“Entourage” or the “Company“), a Canadian producer and distributor of award-winning cannabis products, announced today its financial results for the fiscal year that ended December 31, 2023. The Company reported a total revenue of $54.1 million, mirroring the previous year’s performance, demonstrating resilience...

Continue reading

Harmony Biosciences Reports Strong First Quarter Financial Results and Acceleration of Its Growth Strategy; Advances Pitolisant Franchise to Extend Revenue Potential Beyond 2040; Strenghtens Sleep/Wake Leadership and Diversifies Into Rare Epilepsy

WAKIX® (pitolisant) Net Revenue of $154.6 Million for First Quarter 2024; ~30% Growth Year-over-Year Supplemental New Drug Application for Pitolisant in Idiopathic Hypersomnia Planned for Second Half 2024 On Track Toward Pediatric Exclusivity to Extend WAKIX Exclusivity to September 2030: Pediatric Narcolepsy sNDA PDUFA Date of June 21, 2024; PWS Phase 3 TEMPO Study Initiated in March 2024 Pitolisant Franchise Revenue Potential Extended Beyond 2040 With Next-Generation Formulations; Reports Positive Pharmacokinetic Data on Next-Generation Formulation 1 (NG1); PDUFA Expected in 2026 Strengthens Leadership Position in Sleep/Wake with Licensing of TPM-1116, a Highly Potent and Selective Oral Orexin-2 Receptor Agonist Establishes Potential Billion Dollar Plus Rare Epilepsy Franchise Through Acquisition of Epygenix Therapeutics, Inc. Reiterates...

Continue reading

VAALCO Energy, Inc. Announces Closing of Accretive All Cash Svenska Acquisition

HOUSTON, April 30, 2024 (GLOBE NEWSWIRE) — VAALCO Energy, Inc. (NYSE: EGY; LSE: EGY) (“VAALCO” or the “Company”) today announced that it has closed the acquisition of Svenska Petroleum Exploration AB (“Svenska”), an exploration and production (“E&P”) company based in Stockholm, Sweden (the “Acquisition”). As previously disclosed, Svenska’s primary asset is a 27.39% non-operated working interest in the deepwater producing Baobab field in Block CI-40, offshore Cote d’Ivoire in West Africa. Net purchase price of $40.2 million was fully funded by cash on hand with no issuance of debt or equity.   Transaction Highlights:Immediately accretive to shareholders on key metrics:Following the planned shutdown for maintenance in April, the Baobab field is back on production with a current rate in excess of 5,000 VAALCO working interest...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.